The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metformin in diabetic pancreatic cancer patients: Benefit or not—Multicenter experience.
Onur Esbah
No relevant relationships to disclose
Berna Oksuzoglu
No relevant relationships to disclose
Tulay Eren
No relevant relationships to disclose
Kaan Helvaci
No relevant relationships to disclose
Tunc Guler
No relevant relationships to disclose
Ayse Ocak Duran
No relevant relationships to disclose
Oznur Bal
No relevant relationships to disclose
Nurıye Yıldırım Ozdemir
No relevant relationships to disclose
Sercan Aksoy
No relevant relationships to disclose